Arena Pharma (ARNA) Files $50M Mixed Shelf

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $50 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Units, or a combination thereof.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• Breeze Acquisition Corp. II gets Nasdaq notice for late 10-Q filings
• SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg